Results
Type
Country of origin
Qualifications

Ribavirin | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Ribavirin. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Siegfried
Type: Producer
Origin: Germany
Germany
Zhejiang Chengyi
Type: Producer
Origin: China
China
Euticals
Type: Producer
Origin: Italy
Italy
Yamasa Corp.
Type: Producer
Origin: Japan
Japan
Bidachem
Type: Producer
Origin: Italy
Italy
Star Lake Bioscience
Type: Producer
Origin: China
China
Yuhan Chemical
Type: Producer
Origin: South Korea
South Korea
Jinan Mingxin
Type: Producer
Origin: China
China
Aurobindo
Type: Producer
Origin: India
India
Shaoxing Hantai Pharma
Type: Trader
Origin: China
China

Looking for Ribavirin 36791-04-5?

API | Excipient name:
Ribavirin 
Synonyms:
RBV, Ribavirin, Ribavirina, Ribavirine, Ribavirinum, Tribavirin  
Cas Number:
36791-04-5 
DrugBank number:
DB00811 
Unique Ingredient Identifier:
49717AWG6K

About Ribavirin

You can find a short description about Ribavirin here. Producing a broad-spectrum activity against several RNA and DNA viruses, Ribavirin is a synthetic guanosine nucleoside and antiviral agent that interferes with the synthesis of viral mRNA. It is primarily indicated for use in treating hepatitis C and viral hemorrhagic fevers. HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients It is reported that ribavirin might be only effective in early stages of viral hemorrhagic fevers including Lasser fever, Crimean-Congo hemorrhagic fever, Venezuelan hemorrhagic fever, and Hantavirus infection.

Ribavirin is a prodrug that is metabolized into nucleoside analogs that blocks viral RNA synthesis and viral mRNA capping. Before the development of newer drugs, ribavirin and Peginterferon alfa-2a/Peginterferon alfa-2b dual therapy was considered the first-generation and standard antiviral treatment The dual therapy was administered for 48 weeks in patients with genotype and and 24 weeks in patients with genotype 2 and 3 Newer drugs developed as Hepatitis C viral infection treatments can be used to reduce or eliminate the use of ribavirin, which are associated with serious adverse effects. They also improve therapeutic efficacy in patients with failed Peginterferon alfa-2a/Peginterferon alfa-2b and ribavirin-based therapy. The potential use of ribavirin as a treatment for acute myeloid leukemia is currently under investigation. According to 2017 American Association for the Study of Liver Diseases (AASLD) and 2015 consensus guidelines from the Canadian Association for the Study of the Liver (CASL), ribavirin is typically used as an adjunct therapy to various first-line and second-line combination therapies recommended for each genotypes. Ribavirin is added to decrease relapse rates by accelerating viral clearance early in the treatment course.

Ask the supplier for a certificate of analysis to find out more about the quality of Ribavirin.

Ribavirin manufacturers | traders | suppliers
We have 10 companies offering Ribavirin from 5 different countries.

Get in contact with the supplier of your choice:

  • Zhejiang Chengyi from China
  • Aurobindo from India
  • Shaoxing Hantai Pharma from China
  • Euticals from Italy
  • Siegfried from Germany
  • Star Lake Bioscience from China
  • Yamasa Corp. from Japan
  • Bidachem from Italy
  • Yuhan Chemical from South Korea
  • Jinan Mingxin from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.